StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.69−0.04 (-5.27%)

Close on Nov 20, 2026Market cap $30.91MP/E –Yield –

TELA Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

TELA Bio's revenue for the twelve months ending Jun 30, 2026 was $79.91M, up 6.1% year over year. For fiscal 2025 it was $80.28M, up 15.8% from the year before. The highest annual figure on record is $80.28M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$80.28M+15.8%
FY2024Dec 31, 2024$69.30M+18.6%
FY2023Dec 31, 2023$58.45M+41.1%
FY2022Dec 31, 2022$41.42M+40.6%
FY2021Dec 31, 2021$29.46M+61.8%
FY2020Dec 31, 2020$18.21M+17.9%
FY2019Dec 31, 2019$15.45M+86.7%
FY2018Dec 31, 2018$8.27M+94.9%
FY2017Dec 31, 2017$4.25M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$19.29M-4.5%
Q1 FY2026Mar 31, 2026$19.06M+2.9%
Q4 FY2025Dec 31, 2025$20.87M+18.2%
Q3 FY2025Sep 30, 2025$20.69M+9.1%
Q2 FY2025Jun 30, 2025$20.20M+25.5%
Q1 FY2025Mar 31, 2025$18.52M+11.5%
Q4 FY2024Dec 31, 2024$17.65M+3.8%
Q3 FY2024Sep 30, 2024$18.96M+25.9%
Q2 FY2024Jun 30, 2024$16.09M+11.0%
Q1 FY2024Mar 31, 2024$16.60M+39.4%
Q4 FY2023Dec 31, 2023$17.00M+46.3%
Q3 FY2023Sep 30, 2023$15.05M+34.9%
Q2 FY2023Jun 30, 2023$14.49M+39.3%
Q1 FY2023Mar 31, 2023$11.91M+44.7%
Q4 FY2022Dec 31, 2022$11.62M+38.8%
Q3 FY2022Sep 30, 2022$11.16M+45.8%
Q2 FY2022Jun 30, 2022$10.41M+37.7%
Q1 FY2022Mar 31, 2022$8.23M+40.1%
Q4 FY2021Dec 31, 2021$8.37M+47.8%
Q3 FY2021Sep 30, 2021$7.65M+44.1%
Q2 FY2021Jun 30, 2021$7.56M+115.5%
Q1 FY2021Mar 31, 2021$5.88M+57.7%
Q4 FY2020Dec 31, 2020$5.67M+71.6%
Q3 FY2020Sep 30, 2020$5.31M+60.7%
Q2 FY2020Jun 30, 2020$3.51M+44.5%
Q1 FY2020Mar 31, 2020$3.73M+68.4%
Q2 FY2019Jun 30, 2019$3.30M–
Q1 FY2019Mar 31, 2019$3.31M–
Q4 FY2018Dec 31, 2018$2.43M–
Q3 FY2018Sep 30, 2018$2.21M–

More TELA Bio figures

See a number that looks wrong?